Many factors can influence this time
These results highlight that injectables generally deliver the greatest effect, while oral tablets and daily injections provide moderate but still meaningful reductions
Now, with millions of people taking semaglutide and tirzepatide worldwide, the signal has become impossible to ignore
According to a study by Rumack titled Acetaminophen Poisoning and Toxicity, published in Pediatrics (1975), long-term treatment plans incorporating a combination of therapy, medical monitoring, and support networks lead to better recovery outcomes
9 Many people who require treatment for hyperthyroidism will develop hypothyroidism as a result of that treatment and require thyroid hormone supplementation to maintain healthy thyroid hormone levels

GLP-1 Drug Market Research Report: Size, Share, Trend Analysis By Drug Type (Short-acting, Long-acting, Dual-action), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Indication (Type 2 Diabetes, Obesity, Cardiovascular Diseases), By Administration Route (Subcutaneous Injection, Oral, Inhalation) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035 ID: MRFR/HC/20411-HCR 128 Pages Last Updated: May 15, 2026 GLP-1 Drug Market Market Size Forecast Period2025 - 2035 CAGR (2025 - 2035)13.17% 2024 Market Size$ 10.77 Billion 2025 Market Size$ 12.19 Billion 2035 Market Size$ 42 Billion Key Players Companies such as Novo Nordisk Eli Lilly Sanofi Boehringer Ingelheim AstraZeneca Merck & Co